Cargando…
Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation
Programmed cell death ligand 1 (PD-L1) expression is an important biomarker for predicting response to immunotherapy in clinical practice. Hence, identification and characterization of factors that predict high expression of PD-L1 in patients is critical. Various studies have reported the associatio...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801455/ https://www.ncbi.nlm.nih.gov/pubmed/31561631 http://dx.doi.org/10.3390/ijms20194794 |
_version_ | 1783460575822479360 |
---|---|
author | Lee, Seung Eun Kim, Yu Jin Sung, Minjung Lee, Mi-Sook Han, Joungho Kim, Hong Kwan Choi, Yoon-La |
author_facet | Lee, Seung Eun Kim, Yu Jin Sung, Minjung Lee, Mi-Sook Han, Joungho Kim, Hong Kwan Choi, Yoon-La |
author_sort | Lee, Seung Eun |
collection | PubMed |
description | Programmed cell death ligand 1 (PD-L1) expression is an important biomarker for predicting response to immunotherapy in clinical practice. Hence, identification and characterization of factors that predict high expression of PD-L1 in patients is critical. Various studies have reported the association of PD-L1 expression with driver genetic status in non-small cell cancer; however, the results have been conflicting and inconclusive. We analyzed the relationship between PD-L1 expression and clinicopathological factors including driver genetic alterations in 1000 resected lung cancers using a clinically validated PD-L1 immunohistochemical assay. PD-L1 expression was significantly higher in squamous cell carcinoma (SCC) compared to adenocarcinomas. PD-L1 expression in adenocarcinoma was associated with higher N-stage, solid histologic pattern, EGFR wild type, and ALK positive, but no significant association with the clinicopathological factors in SCC. EGFR mutant adenocarcinomas with distinctive clinicopathologic features, especially solid histologic pattern and higher stage showed higher PD-L1 expression. To the best of our knowledge, this study is the largest to evaluate the association between PD-L1 expression and clinicopathological and molecular features in lung cancer with a highly prevalent EGFR mutation. Therefore, our results are useful to guide the selection of lung cancer, even EGFR-mutated adenocarcinoma patients with PD-L1 expression, for further immunotherapy. |
format | Online Article Text |
id | pubmed-6801455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68014552019-10-31 Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation Lee, Seung Eun Kim, Yu Jin Sung, Minjung Lee, Mi-Sook Han, Joungho Kim, Hong Kwan Choi, Yoon-La Int J Mol Sci Article Programmed cell death ligand 1 (PD-L1) expression is an important biomarker for predicting response to immunotherapy in clinical practice. Hence, identification and characterization of factors that predict high expression of PD-L1 in patients is critical. Various studies have reported the association of PD-L1 expression with driver genetic status in non-small cell cancer; however, the results have been conflicting and inconclusive. We analyzed the relationship between PD-L1 expression and clinicopathological factors including driver genetic alterations in 1000 resected lung cancers using a clinically validated PD-L1 immunohistochemical assay. PD-L1 expression was significantly higher in squamous cell carcinoma (SCC) compared to adenocarcinomas. PD-L1 expression in adenocarcinoma was associated with higher N-stage, solid histologic pattern, EGFR wild type, and ALK positive, but no significant association with the clinicopathological factors in SCC. EGFR mutant adenocarcinomas with distinctive clinicopathologic features, especially solid histologic pattern and higher stage showed higher PD-L1 expression. To the best of our knowledge, this study is the largest to evaluate the association between PD-L1 expression and clinicopathological and molecular features in lung cancer with a highly prevalent EGFR mutation. Therefore, our results are useful to guide the selection of lung cancer, even EGFR-mutated adenocarcinoma patients with PD-L1 expression, for further immunotherapy. MDPI 2019-09-26 /pmc/articles/PMC6801455/ /pubmed/31561631 http://dx.doi.org/10.3390/ijms20194794 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lee, Seung Eun Kim, Yu Jin Sung, Minjung Lee, Mi-Sook Han, Joungho Kim, Hong Kwan Choi, Yoon-La Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation |
title | Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation |
title_full | Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation |
title_fullStr | Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation |
title_full_unstemmed | Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation |
title_short | Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation |
title_sort | association with pd-l1 expression and clinicopathological features in 1000 lung cancers: a large single-institution study of surgically resected lung cancers with a high prevalence of egfr mutation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801455/ https://www.ncbi.nlm.nih.gov/pubmed/31561631 http://dx.doi.org/10.3390/ijms20194794 |
work_keys_str_mv | AT leeseungeun associationwithpdl1expressionandclinicopathologicalfeaturesin1000lungcancersalargesingleinstitutionstudyofsurgicallyresectedlungcancerswithahighprevalenceofegfrmutation AT kimyujin associationwithpdl1expressionandclinicopathologicalfeaturesin1000lungcancersalargesingleinstitutionstudyofsurgicallyresectedlungcancerswithahighprevalenceofegfrmutation AT sungminjung associationwithpdl1expressionandclinicopathologicalfeaturesin1000lungcancersalargesingleinstitutionstudyofsurgicallyresectedlungcancerswithahighprevalenceofegfrmutation AT leemisook associationwithpdl1expressionandclinicopathologicalfeaturesin1000lungcancersalargesingleinstitutionstudyofsurgicallyresectedlungcancerswithahighprevalenceofegfrmutation AT hanjoungho associationwithpdl1expressionandclinicopathologicalfeaturesin1000lungcancersalargesingleinstitutionstudyofsurgicallyresectedlungcancerswithahighprevalenceofegfrmutation AT kimhongkwan associationwithpdl1expressionandclinicopathologicalfeaturesin1000lungcancersalargesingleinstitutionstudyofsurgicallyresectedlungcancerswithahighprevalenceofegfrmutation AT choiyoonla associationwithpdl1expressionandclinicopathologicalfeaturesin1000lungcancersalargesingleinstitutionstudyofsurgicallyresectedlungcancerswithahighprevalenceofegfrmutation |